We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688002:SSERaytron Technology Co., Ltd. Class A Analysis

Data as of 2026-06-13 - not real-time

CN¥129.90

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Raytron Technology trades at ¥129.9, comfortably above its 20‑day (¥128.32) and 50‑day (¥128.66) simple moving averages, yet the MACD remains bearish with a negative histogram, suggesting limited upside momentum. The RSI sits near the neutral zone at 51.7, and the stock is hovering between a support of ¥114.52 and resistance near ¥139.20, while volume is on an upward trend. Valuation metrics are stretched: a trailing P/E of 42.6 exceeds the industry average of 36.8, the price‑to‑book is 8.18, and a discounted cash‑flow model caps fair value at only ¥55.34, indicating the market is pricing in aggressive growth expectations. Fundamentals, however, are robust – revenue surged 71% YoY, gross margin sits at 51.4%, ROE is 20.6%, and the balance sheet shows ample cash (¥2.47 bn) versus modest debt (¥1.30 bn). The dividend is modest (0.12%) with a very low payout ratio (5.3%), underscoring sustainability. Volatility is high at 48% over the past 30 days, but beta is low (0.27), reflecting limited systematic risk.
Given the overvalued pricing, neutral technical stance, and strong growth fundamentals, the stock appears poised for a correction before any further upside can be justified. Investors should watch for price moves toward the support zone and monitor macro‑policy signals in China’s technology sector, which could affect regulatory and geographic risk. The dividend’s safety and solid cash generation support a longer‑term view, but short‑term positioning should be defensive until valuation aligns with fundamentals.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram indicating weakening momentum
  • Current price well above short‑term moving averages but near resistance
  • Extreme overvaluation relative to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong revenue growth (71% YoY) and high operating margins
  • Robust cash position with low debt-to-equity
  • Valuation still stretched, requiring price correction before upside

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic exposure to high‑growth IR imaging and MEMS markets
  • Sustainable dividend and low payout ratio
  • Solid ROE and cash generation supporting future expansion

Key Metrics & Analysis

Financial Health

Revenue Growth71.10%
Profit Margin20.49%
P/E Ratio42.6
ROE20.63%
ROA9.11%
Debt/Equity17.93
P/B Ratio8.2
Op. Cash FlowCN¥2.6B
Free Cash FlowCN¥685.4M
Industry P/E36.8

Technical Analysis

TrendNeutral
RSI51.7
SupportCN¥114.52
ResistanceCN¥139.20
MA 20CN¥128.32
MA 50CN¥128.66
MA 200CN¥100.07
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueCN¥55.34
GradeOvervalued
TypeGrowth
Dividend Yield0.12%

Risk Assessment

Beta0.27
Volatility48.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.